Laura Umbrecht Gulick

Laura Umbrecht Gulick is a partner at Goodwin. Laura regularly represents public and private pharmaceutical, biotechnology, pharma services, and medical device companies and their investors in connection with complex corporate transactions, including mergers and acquisitions, leveraged buyouts, reverse mergers, de-SPAC transactions asset purchases and divestitures as well as joint ventures, carve-out transactions, equity financings, co-investments and licensing, development, and collaboration transactions. She also advises clients on a variety of corporate governance and securities law matters.

Prior to joining Goodwin in 2023, Laura worked at two law firms in connection with a variety of transactions for public and private companies and private equity sponsors.